Sophie Cazanave

Sophie Cazanave

Company: Glympse Bio

Job title: Director of NASH Biology


Accurate Diagnosis of Non-alcoholic Steatohepatitis using Novel Protease Activity-based Liquid Biopsy 11:30 am

Transcriptomic analysis of human liver biopsies across 2 independent cohorts of NAFLD patients revealed that proteases are widely dysregulated in progressive NASH, and panels as few as 13 proteases have the capacity to discriminate F2+ from F0-F1 with high accuracy (AUC> 0.85). Glympse has developed a plasma-based Glympse liquid biopsy (LBx)-NASH, a novel non-invasive method…Read more

day: Post Conference Seminar Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.